AquaPass Ltd. is the developer and manufacturer of innovative solutions for the treatment of fluid overload in heart failure, renal failure, and lymphedema patients.

The treatment is non-invasive and bypasses the renal system. It is intended to be used in the hospital or at home. 

Initial clinical trials confirmed the safety and performance of the system in chronic heart failure (CHF) patients and in end-stage renal disease (ESRD) patients.

Health Care

Life Sciences

AquaPass Ltd

Org chart

Similar companies